SELECTIVE INHIBITION OF THROMBOXANE SYNTHETASE BY DAZOXIBEN INCREASES PROSTACYCLIN PRODUCTION BY LEUCOCYTES IN ANGINA PATIENTS AND HEALTHY VOLUNTEERS
- 17 July 1982
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 320 (8290) , 164
- https://doi.org/10.1016/s0140-6736(82)91137-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- THROMBOXANE SYNTHASE INHIBITION IN PATIENTS WITH ATHEROSCLEROTIC HEART DISEASEThe Lancet, 1981
- UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activityThrombosis Research, 1981
- THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGYThe Lancet, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial CellsJournal of Clinical Investigation, 1980
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Decreased Vascular Prostacyclin in Juvenile-Onset DiabetesNew England Journal of Medicine, 1979
- VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MANThe Lancet, 1979
- Platelet and Blood Vessel Arachidonate Metabolism and InteractionsJournal of Clinical Investigation, 1979